R&D News | pharmaphorum

News

Relief for Chinese biotechs as BIOSECURE Act delayed

US legislation that could have a big impact on the businesses of five biotechs with links to China now looks unlikely to be passed this year.

News

GSK builds neuro, cancer pipeline with trio of deals

GSK has added to its R&D pipeline via partnerships with Muna Therapeutics, Rgenta Therapeutics, and Duality Biologics.

News

transmission electron microscopic (TEM) image depicting influenza A virions

A single mutation could make H5N1 flu a human threat

A single mutation in the H5N1 strain of avian influenza that is infecting cows in the US could make it more likely to infect humans, warn researchers.

News

Atlas closes $450m biotech fund, and other financing news

Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, Maze, and Antag also closed financings this week.

News

Still no clear motive in UnitedHealth CEO killing

Investigations continue into the death of UnitedHealth chief executive Brian Thompson, who was shot and killed by an unknown assailant in New York

News

Genmab expands its pipeline with $630m Scancell deal

Genmab has licensed another anti-glycan antibody for cancer from UK biotech Scancell as it continues to expand its in-house pipeline.

Relief for Chinese biotechs as BIOSECURE Act delayed

GSK builds neuro, cancer pipeline with trio of deals

A single mutation could make H5N1 flu a human threat

Atlas closes $450m biotech fund, and other financing news

Still no clear motive in UnitedHealth CEO killing

Genmab expands its pipeline with $630m Scancell deal

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks